Annual Operating Profit
$4.31 B
-$57.90 M-1.33%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual operaing income is currently $4.31 billion, with the most recent change of -$57.90 million (-1.33%) on 31 December 2023. During the last 3 years, it has risen by +$1.44 billion (+50.12%). VRTX annual operating profit is now -1.33% below its all-time high of $4.37 billion, reached on 31 December 2022.VRTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$1.13 B
+$196.70 M+21.04%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly operating income is currently $1.13 billion, with the most recent change of +$196.70 million (+21.04%) on 30 September 2024. Over the past year, it has increased by +$40.60 million (+3.72%). VRTX quarterly operating profit is now -6.96% below its all-time high of $1.22 billion, reached on 31 March 2024.VRTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$4.24 B
+$40.60 M+0.97%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated TTM operating income is currently $4.24 billion, with the most recent change of +$40.60 million (+0.97%) on 30 September 2024. Over the past year, it has dropped by -$170.70 million (-3.87%). VRTX TTM operating profit is now -5.21% below its all-time high of $4.47 billion, reached on 30 June 2023.VRTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | +3.7% | -3.9% |
| 3 y3 years | +50.1% | +4.5% | +16.6% |
| 5 y5 years | +548.8% | +1006.2% | +426.0% |
VRTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.3% | +50.1% | -7.0% | +21.0% | -5.2% | +16.6% |
| 5 y | 5 years | -1.3% | +548.8% | -7.0% | +1006.2% | -5.2% | +426.0% |
| alltime | all time | -1.3% | +720.2% | -7.0% | +639.2% | -5.2% | +710.3% |
Vertex Pharmaceuticals Incorporated Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.13 B(+21.0%) | $4.24 B(+1.0%) |
| June 2024 | - | $934.90 M(-23.1%) | $4.20 B(-4.6%) |
| Mar 2024 | - | $1.22 B(+27.2%) | $4.40 B(+2.1%) |
| Dec 2023 | $4.31 B(-1.3%) | $956.00 M(-12.4%) | $4.31 B(-2.3%) |
| Sept 2023 | - | $1.09 B(-4.0%) | $4.41 B(-1.4%) |
| June 2023 | - | $1.14 B(+1.1%) | $4.47 B(+0.4%) |
| Mar 2023 | - | $1.12 B(+6.3%) | $4.45 B(+2.0%) |
| Dec 2022 | $4.37 B(+12.2%) | $1.06 B(-8.3%) | $4.37 B(+1.3%) |
| Sept 2022 | - | $1.15 B(+3.0%) | $4.31 B(+1.7%) |
| June 2022 | - | $1.12 B(+8.1%) | $4.24 B(+4.9%) |
| Mar 2022 | - | $1.04 B(+3.3%) | $4.04 B(+3.9%) |
| Dec 2021 | $3.89 B(+35.6%) | $1.00 B(-7.4%) | $3.89 B(+7.0%) |
| Sept 2021 | - | $1.08 B(+17.4%) | $3.63 B(+12.7%) |
| June 2021 | - | $922.10 M(+4.3%) | $3.23 B(+6.4%) |
| Mar 2021 | - | $883.90 M(+18.4%) | $3.03 B(+5.6%) |
| Dec 2020 | $2.87 B(+138.7%) | $746.30 M(+10.7%) | $2.87 B(+7.2%) |
| Sept 2020 | - | $674.04 M(-7.3%) | $2.68 B(+27.2%) |
| June 2020 | - | $727.23 M(+0.7%) | $2.10 B(+27.8%) |
| Mar 2020 | - | $721.82 M(+30.5%) | $1.65 B(+37.0%) |
| Dec 2019 | $1.20 B(+81.0%) | $552.94 M(+440.6%) | $1.20 B(+49.2%) |
| Sept 2019 | - | $102.29 M(-62.1%) | $805.79 M(-11.4%) |
| June 2019 | - | $269.96 M(-2.5%) | $908.97 M(+11.9%) |
| Mar 2019 | - | $276.81 M(+76.6%) | $811.95 M(+22.3%) |
| Dec 2018 | $663.97 M(+69.0%) | $156.73 M(-23.7%) | $663.97 M(+4.8%) |
| Sept 2018 | - | $205.47 M(+18.8%) | $633.36 M(+77.2%) |
| June 2018 | - | $172.94 M(+34.2%) | $357.52 M(+48.5%) |
| Mar 2018 | - | $128.82 M(+2.1%) | $240.81 M(-38.7%) |
| Dec 2017 | $392.83 M(+3408.0%) | $126.12 M(-279.2%) | $392.83 M(+28.1%) |
| Sept 2017 | - | -$70.37 M(-225.1%) | $306.57 M(-14.4%) |
| June 2017 | - | $56.23 M(-80.0%) | $358.22 M(+17.2%) |
| Mar 2017 | - | $280.84 M(+604.5%) | $305.68 M(+2629.8%) |
| Dec 2016 | $11.20 M(-102.4%) | $39.86 M(-313.0%) | $11.20 M(-113.9%) |
| Sept 2016 | - | -$18.72 M(-606.5%) | -$80.85 M(-38.0%) |
| June 2016 | - | $3.70 M(-127.1%) | -$130.33 M(-57.0%) |
| Mar 2016 | - | -$13.64 M(-73.9%) | -$303.06 M(-34.8%) |
| Dec 2015 | -$464.67 M(-27.6%) | -$52.18 M(-23.5%) | -$464.67 M(-17.3%) |
| Sept 2015 | - | -$68.20 M(-59.7%) | -$561.95 M(-5.6%) |
| June 2015 | - | -$169.04 M(-3.5%) | -$595.11 M(-1.9%) |
| Mar 2015 | - | -$175.26 M(+17.3%) | -$606.89 M(-5.4%) |
| Dec 2014 | -$641.49 M(+309.7%) | -$149.46 M(+47.5%) | -$641.49 M(+35.1%) |
| Sept 2014 | - | -$101.36 M(-43.9%) | -$474.65 M(-2.1%) |
| June 2014 | - | -$180.81 M(-13.8%) | -$484.80 M(+34.6%) |
| Mar 2014 | - | -$209.85 M(-1307.7%) | -$360.14 M(+105.0%) |
| Dec 2013 | -$156.59 M(-422.4%) | $17.38 M(-115.6%) | -$175.64 M(-22.3%) |
| Sept 2013 | - | -$111.51 M(+98.6%) | -$225.90 M(+96.8%) |
| June 2013 | - | -$56.16 M(+121.5%) | -$114.77 M(+66.8%) |
| Mar 2013 | - | -$25.35 M(-22.9%) | -$68.79 M(-241.6%) |
| Dec 2012 | $48.57 M(-78.1%) | -$32.89 M(+8669.9%) | $48.57 M(-84.1%) |
| Sept 2012 | - | -$375.00 K(-96.3%) | $306.35 M(-51.2%) |
| June 2012 | - | -$10.18 M(-111.1%) | $627.82 M(+32.8%) |
| Mar 2012 | - | $92.01 M(-59.1%) | $472.84 M(+113.3%) |
| Dec 2011 | $221.69 M(-131.9%) | $224.89 M(-30.0%) | $221.69 M(-228.8%) |
| Sept 2011 | - | $321.09 M(-294.4%) | -$172.09 M(-75.1%) |
| June 2011 | - | -$165.15 M(+3.8%) | -$691.90 M(-0.3%) |
| Mar 2011 | - | -$159.14 M(-5.8%) | -$694.21 M(-0.1%) |
| Dec 2010 | -$694.58 M(+17.2%) | -$168.89 M(-15.0%) | -$694.58 M(+4.7%) |
| Sept 2010 | - | -$198.72 M(+18.7%) | -$663.25 M(+8.4%) |
| June 2010 | - | -$167.46 M(+5.0%) | -$611.98 M(+1.9%) |
| Mar 2010 | - | -$159.50 M(+15.9%) | -$600.58 M(+1.3%) |
| Dec 2009 | -$592.78 M(+29.3%) | -$137.56 M(-6.7%) | -$592.78 M(-0.4%) |
| Sept 2009 | - | -$147.46 M(-5.5%) | -$595.44 M(+3.1%) |
| June 2009 | - | -$156.06 M(+2.9%) | -$577.72 M(+12.8%) |
| Mar 2009 | - | -$151.70 M(+8.2%) | -$511.98 M(+11.7%) |
| Dec 2008 | -$458.38 M(+11.1%) | -$140.22 M(+8.1%) | -$458.38 M(+11.9%) |
| Sept 2008 | - | -$129.74 M(+43.7%) | -$409.63 M(+4.3%) |
| June 2008 | - | -$90.31 M(-7.9%) | -$392.80 M(-8.1%) |
| Mar 2008 | - | -$98.11 M(+7.3%) | -$427.20 M(+3.5%) |
| Dec 2007 | -$412.67 M | -$91.47 M(-19.0%) | -$412.67 M(+16.2%) |
| Sept 2007 | - | -$112.91 M(-9.5%) | -$355.11 M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$124.71 M(+49.2%) | -$302.91 M(+17.9%) |
| Mar 2007 | - | -$83.57 M(+146.5%) | -$256.97 M(+14.0%) |
| Dec 2006 | -$225.39 M(+59.0%) | -$33.91 M(-44.2%) | -$225.39 M(+6.6%) |
| Sept 2006 | - | -$60.71 M(-22.9%) | -$211.48 M(+10.3%) |
| June 2006 | - | -$78.78 M(+51.5%) | -$191.68 M(+25.1%) |
| Mar 2006 | - | -$51.99 M(+160.0%) | -$153.24 M(+8.1%) |
| Dec 2005 | -$141.74 M(+3.3%) | -$20.00 M(-51.1%) | -$141.74 M(-5.4%) |
| Sept 2005 | - | -$40.92 M(+1.4%) | -$149.82 M(+4.8%) |
| June 2005 | - | -$40.34 M(-0.4%) | -$142.93 M(-0.0%) |
| Mar 2005 | - | -$40.49 M(+44.2%) | -$142.99 M(+4.2%) |
| Dec 2004 | -$137.23 M(-20.5%) | -$28.08 M(-17.5%) | -$137.23 M(-7.0%) |
| Sept 2004 | - | -$34.03 M(-15.8%) | -$147.56 M(-6.4%) |
| June 2004 | - | -$40.40 M(+16.3%) | -$157.57 M(-23.6%) |
| Mar 2004 | - | -$34.73 M(-9.6%) | -$206.18 M(+35.4%) |
| Dec 2003 | -$172.70 M(+16.7%) | -$38.41 M(-12.8%) | -$152.24 M(-13.4%) |
| Sept 2003 | - | -$44.04 M(-50.5%) | -$175.86 M(+4.9%) |
| June 2003 | - | -$89.01 M(-563.4%) | -$167.67 M(+63.3%) |
| Mar 2003 | - | $19.21 M(-131.0%) | -$102.69 M(-30.6%) |
| Dec 2002 | -$147.96 M(+28.5%) | -$62.02 M(+73.0%) | -$147.96 M(+1.3%) |
| Sept 2002 | - | -$35.85 M(+49.2%) | -$146.06 M(+11.8%) |
| June 2002 | - | -$24.03 M(-7.8%) | -$130.61 M(+5.3%) |
| Mar 2002 | - | -$26.06 M(-56.6%) | -$124.03 M(+9.4%) |
| Dec 2001 | -$115.10 M(+207.4%) | -$60.12 M(+194.7%) | -$113.36 M(+70.7%) |
| Sept 2001 | - | -$20.40 M(+16.9%) | -$66.41 M(+8.5%) |
| June 2001 | - | -$17.45 M(+13.3%) | -$61.18 M(+78.5%) |
| Mar 2001 | - | -$15.39 M(+17.0%) | -$34.28 M(-6.9%) |
| Dec 2000 | -$37.44 M(-26.0%) | -$13.16 M(-13.2%) | -$36.80 M(+51.8%) |
| Sept 2000 | - | -$15.17 M(-260.5%) | -$24.25 M(-4.4%) |
| June 2000 | - | $9.45 M(-152.7%) | -$25.37 M(-47.1%) |
| Mar 2000 | - | -$17.92 M(+2867.1%) | -$48.00 M(-4.9%) |
| Dec 1999 | -$50.60 M(+5.9%) | -$604.00 K(-96.3%) | -$50.48 M(-34.9%) |
| Sept 1999 | - | -$16.30 M(+23.7%) | -$77.58 M(+22.4%) |
| June 1999 | - | -$13.18 M(-35.4%) | -$63.38 M(+6.0%) |
| Mar 1999 | - | -$20.40 M(-26.4%) | -$59.80 M(+15.7%) |
| Dec 1998 | -$47.80 M(+149.0%) | -$27.70 M(+1219.0%) | -$51.70 M(+69.5%) |
| Sept 1998 | - | -$2.10 M(-78.1%) | -$30.50 M(-10.6%) |
| June 1998 | - | -$9.60 M(-22.0%) | -$34.10 M(+32.7%) |
| Mar 1998 | - | -$12.30 M(+89.2%) | -$25.70 M(+35.3%) |
| Dec 1997 | -$19.20 M(-51.4%) | -$6.50 M(+14.0%) | -$19.00 M(-31.4%) |
| Sept 1997 | - | -$5.70 M(+375.0%) | -$27.70 M(-5.8%) |
| June 1997 | - | -$1.20 M(-78.6%) | -$29.40 M(-19.5%) |
| Mar 1997 | - | -$5.60 M(-63.2%) | -$36.50 M(-7.6%) |
| Dec 1996 | -$39.50 M(+49.1%) | -$15.20 M(+105.4%) | -$39.50 M(+48.5%) |
| Sept 1996 | - | -$7.40 M(-10.8%) | -$26.60 M(-2.2%) |
| June 1996 | - | -$8.30 M(-3.5%) | -$27.20 M(-6.8%) |
| Mar 1996 | - | -$8.60 M(+273.9%) | -$29.20 M(+10.2%) |
| Dec 1995 | -$26.50 M(+28.0%) | -$2.30 M(-71.3%) | -$26.50 M(-18.7%) |
| Sept 1995 | - | -$8.00 M(-22.3%) | -$32.60 M(+14.8%) |
| June 1995 | - | -$10.30 M(+74.6%) | -$28.40 M(+20.9%) |
| Mar 1995 | - | -$5.90 M(-29.8%) | -$23.50 M(+13.0%) |
| Dec 1994 | -$20.70 M(-1825.0%) | -$8.40 M(+121.1%) | -$20.80 M(+447.4%) |
| Sept 1994 | - | -$3.80 M(-29.6%) | -$3.80 M(+31.0%) |
| June 1994 | - | -$5.40 M(+68.8%) | -$2.90 M(-293.3%) |
| Mar 1994 | - | -$3.20 M(-137.2%) | $1.50 M(+25.0%) |
| Dec 1993 | $1.20 M(-112.0%) | $8.60 M(-396.6%) | $1.20 M(-111.7%) |
| Sept 1993 | - | -$2.90 M(+190.0%) | -$10.30 M(+3.0%) |
| June 1993 | - | -$1.00 M(-71.4%) | -$10.00 M(-11.5%) |
| Mar 1993 | - | -$3.50 M(+20.7%) | -$11.30 M(+14.1%) |
| Dec 1992 | -$10.00 M(+78.6%) | -$2.90 M(+11.5%) | -$9.90 M(+13.8%) |
| Sept 1992 | - | -$2.60 M(+13.0%) | -$8.70 M(+16.0%) |
| June 1992 | - | -$2.30 M(+9.5%) | -$7.50 M(+15.4%) |
| Mar 1992 | - | -$2.10 M(+23.5%) | -$6.50 M(+80.6%) |
| Dec 1991 | -$5.60 M(+36.6%) | -$1.70 M(+21.4%) | -$3.60 M(-53.2%) |
| Sept 1991 | - | -$1.40 M(+7.7%) | -$7.70 M(+35.1%) |
| June 1991 | - | -$1.30 M(-262.5%) | -$5.70 M(+50.0%) |
| Mar 1991 | - | $800.00 K(-113.8%) | -$3.80 M(-7.3%) |
| Dec 1990 | -$4.10 M | -$5.80 M(-1066.7%) | -$4.10 M(-341.2%) |
| Sept 1990 | - | $600.00 K(0.0%) | $1.70 M(+54.5%) |
| June 1990 | - | $600.00 K(+20.0%) | $1.10 M(+120.0%) |
| Mar 1990 | - | $500.00 K | $500.00 K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual operaing income?
- What is the all time high annual operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly operating income?
- What is the all time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM operating income?
- What is the all time high TTM operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual operaing income?
The current annual operating profit of VRTX is $4.31 B
What is the all time high annual operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual operaing income is $4.37 B
What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?
Over the past year, VRTX annual operaing income has changed by -$57.90 M (-1.33%)
What is Vertex Pharmaceuticals Incorporated quarterly operating income?
The current quarterly operating profit of VRTX is $1.13 B
What is the all time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly operating income is $1.22 B
What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
Over the past year, VRTX quarterly operating income has changed by +$40.60 M (+3.72%)
What is Vertex Pharmaceuticals Incorporated TTM operating income?
The current TTM operating profit of VRTX is $4.24 B
What is the all time high TTM operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM operating income is $4.47 B
What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?
Over the past year, VRTX TTM operating income has changed by -$170.70 M (-3.87%)